Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Fanconi Anemia · Head and Neck Squamous Cell Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Medizinische Hochschule Hannover, Hanover, Germany
Contact: Study coordinator (A Resposible Person Designated by the Sponsor) · investigacion@mfar.net · +34 93 434 44 12Contact: Principal Investigator (Principal Investigator Designated by the Sponsor, M.D.; Ph.D.)Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain
Contact: Study coordinator (A Responsible Person Designated by the Sponsor) · investigacion@mfar.net · +34 93 434 44 12Contact: Principal Investigator (Principal Investigator Designated by the Sponsor, M.D.;Ph.D.)
Study leads
Jordi Surrallés, M.D.; Ph.D.
Study Chair
Sant Pau's Hospital Research Institute